Picard Medical reports 85% Q1 2026 revenue growth, positive gross margins
Picard Medical achieved $1.2M in Q1 2026 revenue with 24% gross margins and reduced debt by $9.5M. The artificial heart maker is making progress toward profitability after its 2025 IPO that raised $17.4M.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day